System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Larisa J Geskin is an expert in Dermatology at Columbia University Medical Center (United States). As of October 2026, ScienceLeadR ranks Larisa J Geskin in the top 1% of experts worldwide for Lymphoma and Lymphoproliferative Disorders. Larisa J Geskin has authored 356 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 2 of them ongoing. SLR score: 1,380 (community average: 125). How the SLR is computed.

LeadR Profile

Larisa J Geskin Columbia University Medical Center United States
1 380 ScienceLeadR Reputation 1380

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Hematology - Oncology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Columbia University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 356

Citations

Citations: 7 008 1st author: 18 Last author: 173 Unique author: 5

Main journals

J Invest Dermatol 46
J Am Acad Dermatol 33
Blood 27
Eur J Cancer 25
JAAD Case Rep 25

Best Journals

J Clin Oncol 5
Nat Rev Dis Primers 2
Lancet Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Inflation-Adjusted Medicare Reimbursement for Common Dermatologic Procedures.
PMID 42842262 — inflation, economic, skin diseases, medicare		JAMA Dermatol20260
Cutaneous Lymphoma International Prognostic Index and Risk Stratification in Advanced Mycosis Fungoides and Sézary Syndrome.
PMID 42842270 — mycosis fungoides, sezary syndrome, lymphoma, disease progression, skin diseases, diagnosis		JAMA Dermatol20261
Utilization, cost, and specialty distribution of topical ruxolitinib prescribing in Medicare Part D, 2018-2024: A cross-sectional study.
PMID 42761726 — epidemiology, cross-sectional studies, drug utilization, vitiligo, medicare part d, tacrolimus, medicare, dermatitis, atopic		JAAD Int20260
Persistent Agmination of Lymphomatoid Papulosis with Features of Lymphomatoid Papulosis in Both the Regressing Papular Component and the Persistent Patch: A Case Report and Review of the Literature.
PMID 42758883 — cells, mycosis fungoides, lymphoma, lymphomatoid papulosis, biopsy		Am J Dermatopathol20260
Recent Incidence Trends for Cutaneous T-Cell Lymphoma in the United States: A Surveillance, Epidemiology, and End Results (SEER) Database Analysis, 2000-2022.
PMID 42685904 — cells, epidemiology, mycosis fungoides, incidence, lymphoma, lymphoma, t-cell, cutaneous, t-lymphocytes, dermatology, lymphoma, t-cell		J Am Acad Dermatol20260

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 6
Phase 2 5
Phase 3 4
Early Phase 1 1
Phase 1 1
Phase 4 1

By status:

Completed 11
Recruiting 4
Active not recruiting 1
Unknown 1
Withdrawn 1

By type:

Interventional 13
Observational 5

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 0
multicentric5to9 1
multicentricup10 8

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Photopheresis in Early stage Mycosis Fungoides
NCT05680558 — cells, methoxsalen, photopheresis, mycosis fungoides, lymphoma, multiple chronic conditions, solutions, lymphoma, t-cell, cutaneous, therapeutics, t-lymphocytes, lymphoma, t-cell		Phase 2Recruiting2021
StrataCTX as a Steroid Sparing Device
NCT04087629 — marketing, dermatitis, drug therapy, immunotherapy, therapeutics, steroids, chemotherapy		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS